X Square Capital, LLC Lannett CO Inc Transaction History

X Square Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$5.28 - $9.64 $331,980 - $606,115	-62,875 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$5.75 - $7.13 $173,218 - $214,791	-30,125 Reduced 32.39%	62,875 $410,000
Q3 2020 Nov 02, 2020	SELL	$4.9 - $7.12 $770,525 - $1.12 Million	-157,250 Reduced 62.84%	93,000 $568,000
Q2 2020 Aug 13, 2020	SELL	$6.43 - $9.86 $178,432 - $273,615	-27,750 Reduced 9.98%	250,250 $1.82 Million
Q1 2020 May 19, 2020	BUY	$6.36 - $10.05 $623,280 - $984,900	98,000 Added 54.44%	278,000 $1.93 Million
Q4 2019 Feb 12, 2020	BUY	$8.49 - $12.81 $1.53 Million - $2.31 Million	180,000 New	180,000 $1.59 Million
Q3 2019 Nov 14, 2019	SELL	$5.58 - $14.47 $993,240 - $2.58 Million	-178,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.35 - $9.82 $16,049 - $29,460	3,000 Added 1.71%	178,000 $1.4 Million
Q3 2018 Nov 13, 2018	BUY	$4.75 - $14.5 $831,250 - $2.54 Million	175,000 New	175,000 $831,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of X Square Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on X Square Capital, LLC with notifications on news.